Kamakura, Japan

Kiyomi Tamatsu


Average Co-Inventor Count = 12.0

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 1989-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Kiyomi Tamatsu: Innovator in Pharmaceutical Chemistry**

Introduction

Kiyomi Tamatsu is a notable inventor based in Kamakura, Japan, recognized for her significant contributions to pharmaceutical chemistry. With a portfolio of seven patents, she focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Tamatsu's latest achievements include several patents related to piperidine derivatives. One of her most recent patents details a novel piperidine derivative characterized by its formula (I) and includes pharmacologically acceptable salts. This compound features various substituents such as anthraquinone and various chain groups, emphasizing her work on versatile pharmaceutical compositions aimed at addressing complex health challenges.

Career Highlights

Working at Eisai Company, Limited, Kiyomi has not only expanded the company’s capacity for innovation but also fortified its dedication to developing effective pharmaceuticals. Her passion for research and commitment to advancing medicinal chemistry have underscored her career, making her a valuable asset to the scientific community.

Collaborations

Throughout her career, Tamatsu has collaborated with esteemed colleagues such as Hachiro Sugimoto and Takaharu Nakamura. These partnerships have fostered an environment of creativity and knowledge sharing, resulting in groundbreaking developments in the field of pharmaceutical sciences.

Conclusion

Kiyomi Tamatsu stands out as a prominent inventor whose work continues to influence the landscape of pharmaceutical innovation. Through her patents and collaborations, she exemplifies the spirit of discovery and the importance of scientific advancement in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…